View Post

Flu Vaccine Changes Confirmed for 2021-2022

In COVID-19, Latest News by Precision Vaccinations

The World Health Organization (WHO) announced that the influenza vaccine selection committee finalized its recommendations for the Northern Hemisphere's 2021-22 flu season.
These recommendations were made within the context of the ongoing COVID-19 pandemic. Overall, record-low levels of influenza detections were reported, and fewer viruses were available for characterization during September 2020 to January 2021 time period than in previous years, said the WHO.

View Post

COVAX Commences Delivering 2 Billion COVID-19 Vaccines

In COVID-19, Latest News by Precision Vaccinations

The African country of Ghana became the first country outside India to receive COVID-19 vaccines from the COVAX Facility.
On February 23, COVAX shipped 600,000 doses of the AstraZeneca/ Oxford COVID-19 vaccine. These AstraZeneca COVID-19 vaccines were licensed to Serum Institute of India, and are known as ‘CoviShield.’
The AstraZeneca COVID-19 vaccine, formerly known as ChAdOx1 nCoV-19, is made from a virus (ChAdOx1), a weakened version of a common cold virus (adenovirus).

View Post

XDR Typhoid Fever Cases Found in the USA

In COVID-19, Latest News by Precision Vaccinations

The US Centers for Disease Control and Prevention (CDC) announced nine extensively drug-resistant (XDR) typhoid fever cases in the USA unrelated to international travel.
Additionally, the CDC’s Health Advisory Network issued an Alert on February 12, 2021, stating an ongoing outbreak of XDR typhoid fever has sickened more than 5,000 people in the Islamic Republic of Pakistan since 2016.

View Post

Veklury Use While Pregnant to be Studied

In COVID-19, Latest News by Precision Vaccinations

A recent study funded by the National Institutes of Health (NIH) will evaluate the effects of Veklury (remdesivir) in pregnant women who are being treated for COVID-19. 
This NIH study announced on February 17, 2021, aims to determine how pregnant women metabolize Veklury and any potential side effects.
The study will be conducted at 17 sites in the continental United States and Puerto Rico. It will be led by the NIH-funded International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network.

View Post

Editorial: U.S. FDA’s Experience with COVID-19 Antibody Tests

In COVID-19, Latest News by Precision Vaccinations

An editorial published by The New England Journal of Medicine (NEJM) highlights ‘establishing robust and coordinated national and international mechanisms for generating evidence and gathering, sharing, and disseminating information will be critical to ending the current pandemic and addressing future public health emergencies.’

View Post

Innovative Vaccine Technologies Are Disrupting Disease X

In COVID-19, Latest News by Precision Vaccinations

Vaccines are one of our most potent tools against infectious diseases, stated GAVI, the Vaccine Alliance.
Vaccines enabled the eradication of smallpox, and they have helped to reduce the number of polio cases by more than 99% since 1988, saving more than 13 million children from paralysis, add this editorial by Melanie Saville, Director, Coalition for Epidemic Preparedness Innovations (CEPI) published on February 11, 2021.
Excerpts from Saville’s editorial continue below.

View Post

What Causes Herpes Virus Flare-Ups?

In COVID-19, Latest News by Precision Vaccinations

University of Virginia (UVA) researchers have offered new insights on what causes herpes simplex virus (HSV-1) to flare up, explaining how stress, illness, and even sunburn can trigger unwanted outbreaks.
These researchers identified HSV-1 co-opts an innate immune pathway resulting from IL-1 stimulation of neurons to induce reactivation.
The discovery could lead to new ways to prevent cold sores and recurrent herpes-related eye disease from reoccurring, the researchers reported on February 11, 2021

View Post

What Causes Sudden Herpes Virus Outbreaks?

In COVID-19, Latest News by Precision Vaccinations

University of Virginia (UVA) researchers have offered new insights on what causes herpes simplex virus (HSV-1) to flare up, explaining how stress, illness, and even sunburn can trigger unwanted outbreaks.
These researchers identified HSV-1 co-opts an innate immune pathway resulting from IL-1 stimulation of neurons to induce reactivation.
The discovery could lead to new ways to prevent cold sores and recurrent herpes-related eye disease from reoccurring, the researchers reported on February 11, 2021